Relay Therapeutics Inc. (RLAY)

3.15

-0.26 (-7.62%)

At close: Mar 03, 2025, 3:59 PM

3.21

1.74%

After-hours: Mar 03, 2025, 04:18 PM EST

Relay Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-337.71M	-341.97M	-290.51M	-363.87M	-52.41M	-75.31M	-48.78M
Depreciation & Amortization	-6.85M	5.27M	4.13M	3.92M	3.55M	2.85M	2.15M
Stock-Based Compensation	94.14M	86.03M	56.14M	48.45M	31.96M	4.46M	2.89M
Other Working Capital	n/a	-35.28M	9.16M	277K	571K	1.31M	-1.63M
Other Non-Cash Items	1.31M	-17.18M	-10.49M	137.69M	-416K	-2.44M	9K
Deferred Income Tax	n/a	n/a	n/a	2.05M	n/a	n/a	n/a
Change in Working Capital	n/a	-32.46M	11.25M	97.34M	-85.17M	4.31M	-400K
Operating Cash Flow	-249.11M	-300.32M	-229.49M	-74.41M	-102.49M	-66.13M	-44.13M
Capital Expenditures	-2.02M	-4.13M	-9.06M	-3.47M	-1.93M	-8M	-1.69M
Acquisitions	n/a	n/a	179.68M	-25.3M	-83.6M	20K	7K
Purchase of Investments	-650.63M	-385.54M	-535.42M	-980.66M	-266.45M	-553.52M	n/a
Sales Maturities Of Investments	611.46M	647.3M	355.74M	529.92M	350.06M	242.47M	n/a
Other Investing Acitivies	101K	n/a	-179.68M	-450.74M	83.6M	-311.02M	7K
Investing Cash Flow	-41.08M	257.63M	-188.75M	-479.51M	81.67M	-319.02M	-1.68M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	1.48M	n/a	n/a	n/a	n/a	n/a	-82K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4.26M	4.47M	5.17M	5.88M	1.22M	5.61M	394.97M
Financial Cash Flow	270.15M	34.75M	289.91M	388.09M	426.51M	5.61M	394.97M
Net Cash Flow	-20.04M	-7.93M	-128.32M	-165.83M	405.69M	-379.55M	349.16M
Free Cash Flow	-251.13M	-304.44M	-238.55M	-77.88M	-104.42M	-74.14M	-45.82M